Dan, a Cleveland-based lawyer recognized with stage 4 pancreatic most cancers simply earlier than turning 41, shared his expertise in an interview with CURE. He inspired sufferers to ask questions, search a number of opinions and use sources like clinicaltrials.gov alongside their oncologist. Immediately, he’s 45, in full remission and treatment-free.
Dan determined to pursue scientific trials after recognizing that chemotherapy wouldn’t be a long-lasting answer and commenced asking early what choices may come subsequent whereas his most cancers was nonetheless responding. He described how self-advocacy, second opinions and researching trials based mostly on his genetic markers helped open further therapy alternatives.
Transcript
How did you determine to take part in a scientific trial, and what influenced your choice to pursue an experimental therapy?
I did two scientific trials. The primary one was an immunotherapy and a PARP inhibitor. I did Keytruda (pembrolizumab) and Lynparza (olaparib) for about two years, after which the second was an early-stage trial. Each of them have been by Memorial Sloan Kettering Most cancers Middle.
I knew each from the data inside my household and thru conversations with my treating docs on the clinic that chemotherapy was solely going to work for thus lengthy, or my physique would solely be capable to tolerate chemotherapy for thus lengthy. That was not an finish state. That was step one of hopefully at the very least just a few steps.
As soon as we acquired settled again in Cleveland, as soon as I began chemotherapy, and as soon as I used to be settled into that routine, we began asking questions of my oncologist on the Cleveland Clinic: what trials was the clinic concerned in? What choices and alternatives did they see for me? We had these conversations throughout the Cleveland Clinic world, after which my household started wanting by clinicaltrials.gov. They have been comfy sufficient with the vocabulary and every little thing else to pinpoint choices based mostly on the genetic markers I had, the stage of the illness (which was stage 4) and the truth that my tumors have been responding to chemotherapy. They have been in a position to establish completely different hospitals and teams across the nation engaged in pancreatic most cancers trials that I’d finally be eligible for.
About midway by my chemotherapy, they began sending messages, saying, “Hey, you guys are operating these trials. We’d like extra info. May we get a secondary session with you?” We went by the entire clinic onboarding course of, the insurance coverage course of, and ended up having consults with each the MSK staff and the MD Anderson staff. By means of that, little by little, we acquired extra info on what I’d be eligible for, and we ended up making choices about which paths to pursue.
The vital factor about that — there are a few issues. Primary: sufferers have to advocate for themselves. They should ask questions as early as doable: “Is that this working? What’s subsequent? What can I do subsequent? How can I discover out what to do subsequent?” If that includes seeing different docs, no physician needs to be upset that you simply’re in search of further opinions. It’s unusual, sufferers dealing with one thing as tough as stage 4 pancreatic most cancers gained’t essentially wish to let their physician know they’re seeing one other physician, or they won’t wish to ask about different docs as a result of they don’t wish to be rude, harm somebody’s emotions, or suppose the physician will get aggravated. Any physician I’ve met doesn’t suppose that manner.
Sufferers have to really feel comfy asking for secondary consults, different opinions, and extra alternatives. Not each oncologist has all the data. Totally different individuals are doing various things at completely different instances, and treating oncologists aren’t essentially the identical folks conducting the trials. The extra info you may get, the extra questions you possibly can ask, and the extra conversations you possibly can have, the upper the likelihood you’ll uncover alternatives your treating oncologists didn’t know existed.
Exterior of conversations together with your physician, if you happen to can work out use clinicaltrials.gov, that may be a nice useful resource. It’s not very user-friendly, and the vocabulary may be tough, however ChatGPT plus clinicaltrials.gov may help establish potential trials you possibly can then focus on with docs who may need different alternatives. I’d actually encourage folks to do each of these issues to the extent they will.
Transcript has been edited for readability and conciseness.
For extra information on most cancers updates, analysis and training, don’t neglect to
